Angiotensin Converting Enzyme

PHILADELPHIA — In patients with HF with reduced ejection fraction, the four pillars of optimal medical therapy should be started as soon as possible, a speaker said here.

Angiotensin receptor blockers don’t significantly differ compared with ACE inhibitors as first-line treatment for patients with hypertension, but do present with a better safety profile, researchers reported.

Older adults who received antihypertensive drugs that crossed the blood-brain barrier demonstrated improved memory recall compared with those who received other types of antihypertensive drugs, according to new results.

At 10 years, patients with three-vessel or left main disease who underwent PCI or CABG were more likely to survive if they were taking optimal medical therapy at 5 years, researchers reported.

Among veterans with HIV and new-onset hypertension, beta-blockers were independently associated with increased risk for incident CVD or death compared with ACE inhibitors or angiotensin receptor blockers, researchers reported.

Safety assessment of ACE inhibitors and angiotensin receptor blockers in patients with high BP and COVID-19.

Long-term treatment with beta-blockers, ACE inhibitors or angiotensin receptor blockers was associated with improvements in aortic dissection treatment, according to data published in JAMA Network Open.

A study that indicated using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers was not linked to an increased rate of COVID-19 infection or mortality was the top story in cardiology last week.

Low serum testosterone levels may predispose older men to worse COVID-19 outcomes and could explain the higher coronavirus case fatality rate among men compared with women, according to a literature review.